Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 304-308 , December 2008

Role of Bladder Capacity in Assessing the Effectiveness of Antimuscarinic Agents on Nocturia in Patients with Overactive Bladders

Received 4 January 2008 ,Revised 24 January 2008 ,Accepted 4 April 2008.

References 

  1. Coyne KS , Zhou Z , Bhattacharyya SK , Thompson CL , Dhawan R , Versi E . The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA . BJU Int . 2003;92:948–954
  2. Chapple C , Steers W , Norton P , et al.   A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder . BJU Int . 2005;95:993–1001
  3. Brubaker L , Fitzgerald MP . Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms . Int Urogynecol J Pelvic Floor Dysfunct . 2007;18:737–741
  4. van Kerrebroeck P , Abrams P , Chaikin D , et al.   The standardisation of terminology in nocturia: report from the standardisation Sub-committee of the International Continence Society . Neurourol Urodyn . 2002;21:179–183
  5. Weiss JP , Blaivas JG , Stember DS , Chaikin DC . Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices . Neurourol Urodyn . 1999;18:559–565
  6. Asplund R , Sundberg B , Bengtsson P . Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study . Br J Urol . 1998;82:642–646
  7. Rembratt A , Norgaard JP , Andersson KE . Differences between nocturics and non-nocturics in voiding patterns: an analysis of frequency-volume charts from community-dwelling elderly . BJU Int . 2003;91:45–50
  8. Weiss JP , Blaivas JG , Jones M , Wang JT , Guan Z . Age related pathogenesis of nocturia in patients with overactive bladder . J Urol . 2007;178:548–551
  9. Asplund R . Pharmacotherapy for nocturia in the elderly patient . Drugs Aging . 2007;24:325–343
  10. Kreder KJ , Brubaker L , Mainprize T . Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone . BJU Int . 2003;92:418–421
  11. Johnson TM , Burgio KL , Redden DT , Wright KC , Goode PS . Effects of behavioral and drug therapy on nocturia in older incontinent women . J Am Geriatr Soc . 2005;53:846–850
  12. Reiz JL , Salem P , Darke AC . Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin . J Clin Pharmacol . 2007;47:351–357
  13. Locher JL , Goode PS , Roth DL , Worrell RL , Burgio KL . Reliability assessment of the bladder diary for urinary incontinence in older women . J Gerontol A Biol Sci Med Sci . 2001;56:M32–M35
  14. Ku JH , Jeong IG , Lim DJ , Byun SS , Paick JS , Oh SJ . Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden . Neurourol Urodyn . 2004;23:331–335
  15. van Melick HH , Gisolf KW , Eckhardt MD , van Venrooij GE , Boon TA . One 24-hour frequency-volume chart in a woman with objective urinary motor urge incontinence is sufficient . Urology . 2001;58:188–192
  16. Dmochowski RR , Sanders SW , Appell RA , Nitti VW , Davila GW . Bladder-health diaries: an assessment of 3-day vs 7-day entries . BJU Int . 2005;96:1049–1054

PII: S1016-3190(08)60055-5

doi: 10.1016/S1016-3190(08)60055-5

Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 304-308 , December 2008